Evaluating Progestogens for Preventing Preterm Birth International Collaborative (EPPPIC): Meta-analysis of Individual Participant Data from Randomised Controlled Trials

B. W. Mol, S. Wood, L. Rode, A. Tabor, M. M. Aboulghar, R. Porcher, M. V. Senat, R. Bagga, S. Rajaram, A. Azargoon, E. Bahrami, A. Nassar, E. Schuit, M. A. Van Os, C. A. Crowther, Z. Alfirevic, L. Beresford, K. C. Dietz, L. Duley, A. HodkinsonA. Llewellyn, J. E. Norman, J. Norrie, S. Sharif, M. Simmonds, L. A. Stewart, R. A.E. Walker, T. Walley, K. Wright, S. C. Blackwell, S. N. Caritis, C. A. Combs, J. M. Croswell, A. F. Das, K. Dickersin, A. Elimian, W. A. Grobman, K. A. Maurel, D. S. McKenna, K. Moley, J. Mueller, J. M. O'Brien, D. J. Rouse, C. Sakala, J. L. Simpson, K. Smith, E. A. Thom, E. P. Whitlock

Research output: Contribution to journalComment / DebateOtherpeer-review


(Abstracted from Lancet 2021;397:1183-1194) Preterm birth is the most common cause of neonatal morbidity and mortality. When infants are born preterm, they are at increased risk for having difficulties at birth, health problems throughout infancy, and death during the first year of life.

Original languageEnglish
Pages (from-to)464-466
Number of pages3
JournalObstetrical & Gynecological Survey
Issue number8
Publication statusPublished - Aug 2021
Externally publishedYes

Cite this